Citations

Clear

6274 citation(s) found for "To, Andrew".

Gynecomastia in a Patient Taking Meloxicam—A Case Report
Rosas, Steven , Deyo-Svendsen, Mark , Oldfather, Rachel Z., Israel, T. Andrew , Weisenbeck, Emily R., Rosas, Steven L , Deyo-Svendsen, Mark E , Phillips, Michael R., Phillips, Michael

Mayo Clinic

Journal of Primary Care & Community Health | September 19, 2020 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/2150132720952622 | PMID 32951498 Get It

Gynecomastia is benign enlargement of glandular tissue in the male breast. It occurs due to an imbalance of estrogen and testosterone. It may be unilateral or bilateral. Physiologic gynecomastia commonly occurs in infants and during puberty and is self-limited. Gynecomastia may affect up to 50% of adult men over age 50 years old and can be related to underlying medical illness or caused by certain medications. Known causative agents include anti-androgenic and estrogenic drugs. Probable agents include alcohol and anti-ulcer, psychoactive, and antiretroviral medications. Non-steroidal anti-inflammatory drugs (NSAIDs) are not commonly associated with the development of gynecomastia. This case presents an instance in which the NSAID, meloxicam, was the only identified variable in a patient who developed unilateral gynecomastia. His breast tenderness and abnormal exam resolved spontaneously within 4 weeks of cessation of meloxicam therapy.
Changes in Management of Type 2 Diabetes Before and After Severe Hypoglycemia
Vijayakumar, Pavithra , Liu, Shuling , McCoy, Rozalina G. , Karter, Andrew J. , Lipska, Kasia J. , McCoy, Rozalina Grubina , Lipska, Kasia J

Mayo Clinic

Diabetes Care | September 18, 2020 | Volume: 43 | Issue: 11 | Pages: e188-e189

10.2337/dc20-0458 | PMID 32943439 Get It

A novel engineered purified exosome product patch for tendon healing: An explant in an ex vivo model
Shi, Guidong , Wang, Zhanwen , Thoreson, Andrew R. , Jacobson, Daniel S. , Amadio, Peter C. , Behfar, Atta , Moran, Steven L. , Zhao, Chunfeng , Wang, Yicun , Zhao, Chunfeng , Behfar, Atta , Wang, Yicun , Shi, Guidong

Mayo Clinic

Journal of Orthopaedic Research | September 16, 2020 | Volume: 39 | Issue: 8 | Pages: 1825-1837

10.1002/jor.24859 | PMID 32936480 Get It

AbstractReducing tendon failure after repair remains a challenge due to its poor intrinsic healing ability. The purpose of this study is to investigate the effect of a novel tissue‐engineered purified exosome product (PEP) patch on tendon healing in a canine ex vivo model. Lacerated flexor digitorum profundus (FDP) tendons from three canines' paws underwent simulated repair with Tisseel patch alone or biopotentiated with PEP. For the ex vivo model, FDP tendons were randomly divided into three groups: FDP tendon repair alone group (Control), Tisseel patch alone group, and the Tisseel plus PEP (TEPEP) patch group. Following 4 weeks of tissue culture, the failure load, stiffness, histology, and gene expression of the healing tendon were evaluated. Transmission electron microscopy revealed that in exosomes of PEP the diameters ranged from 93.70 to 124.65 nm, and the patch release test showed this TEPEP patch could stably release the extracellular vesicle over 2 weeks. The failure strength of the tendon in the TEPEP patch group was significantly higher than that of the Control group and Tisseel alone group. The results of histology showed that the TEPEP patch group had the smallest healing gap and the largest number of fibroblasts on the surface of the injured tendon. Quantitative reverse transcription polymerase chain reaction showed that TEPEP patch increased the expression of collagen type III, matrix metallopeptidase 2 (MMP2), MMP3, MMP14, and reduced the expression of transforming growth factor β1, interleukin 6. This study shows that the TEPEP patch could promote tendon repair by reducing gap formation and inflammatory response, increasing the activity of endogenous cells, and formation of type III collagen.
Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function
Đenić, Aleksandar , Elsherbiny, Hisham , Leibovich, Bradley C. , Thompson, R. Houston, Ricaurte, Luisa , Narasimhan, Ramya , Kremers, Walter K. , Alexander, Mariam P., Lerman, Lilach O. , Ricaurte Archila, Luisa, Narasimhan, Ramya , Rule, Andrew D , Denic, Aleksandar , Kremers, Walter K , Mullan, Aidan F. , Lieske, John C. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | September 16, 2020 | Volume: 31 | Issue: 11 | Pages: 2642-2652

10.1681/asn.2020040449 | PMID 32938650 Get It

Significance Statement Predicting outcomes on the basis of renal histology after a radical nephrectomy has been limited to studies with small sample sizes, short follow-ups, and only a descriptive characterization of histology. In this study of 936 patients followed up for a median of 6.4 years after establishing a new baseline kidney function following radical nephrectomy, the authors used morphometric methods to quantitatively characterize microstructural features on large renal wedge sections. Findings of larger nephrons and more extensive glomerulosclerosis and interstitial fibrosis predicted progressive CKD; interstitial fibrosis also predicted mortality from causes other than cancer. These findings provide insight into the important microstructural features of “generic” CKD in patients without a specific kidney disease and support the use of quantitative methods to evaluate renal histology after a radical nephrectomy to determine patients’ long-term risks. Background Nephron hypertrophy and nephrosclerosis may be important determinants of CKD and mortality. However, studies of outcomes associated with these microstructural features have been limited to small tissue specimens from patients selected for either good kidney health or known kidney disease. Methods To determine whether microstructural features are predictive of progressive CKD and mortality outcomes, we studied patients who underwent a radical nephrectomy for a tumor. Large wedge sections of renal parenchyma distal to the tumor were stained and scanned into high-resolution images; we annotated the cortex and all glomeruli to calculate glomerular volume, cortex volume per glomerulus, and percentage of globally sclerotic glomeruli. Morphometric measurements also included percentages of artery luminal stenosis and interstitial fibrosis/tubular atrophy (IF/TA) of the cortex. At follow-up visits every 6–12 months, we determined which patients experienced progressive CKD (defined as dialysis, kidney transplantation, or a 40% decline from postnephrectomy eGFR). Cox models for these outcomes were adjusted for age, sex, body mass index, hypertension, diabetes, smoking, eGFR, and proteinuria. Results Among 936 patients (mean age, 64 years; postnephrectomy baseline eGFR, 48 ml/min per 1.73 m 2 ), 117 progressive CKD events, 183 noncancer deaths, and 116 cancer deaths occurred during a median follow-up of 6.4 years. Larger glomerular volume, larger cortex per glomerulus, and higher percentage of globally sclerotic glomeruli or IF/TA predicted progressive CKD. Higher percentage IF/TA also predicted noncancer mortality. Microstructural features did not predict cancer mortality or recurrence. Conclusions After a radical nephrectomy, larger nephrons and nephrosclerosis predicted progressive CKD, and IF/TA predicted noncancer mortality. Morphometric analysis of renal parenchyma can predict noncancer clinical events in patients long after their radical nephrectomy.
Retrospective Review of Clinical Utility of Shotgun Metagenomic Sequencing Testing of Cerebrospinal Fluid from a U.S. Tertiary Care Medical Center
Rodino, Kyle G. , Toledano, Michel , Norgan, Andrew P. , Pritt, Bobbi S. , Binnicker, Matthew J. , Yao, Joseph D. , Aksamit, Allen J. , Patel, Robin , Patel, Robin , Pritt, Bobbi S , Norgan, Andrew P

Mayo Clinic

Journal of Clinical Microbiology | September 16, 2020 | Volume: 58 | Issue: 12 | Pages: No page available

10.1128/jcm.01729-20 | PMID 32938739 Get It

Shotgun metagenomic sequencing can detect nucleic acids from bacteria, fungi, viruses, and/or parasites in clinical specimens; however, little data exist to guide its optimal application to clinical practice. We retrospectively reviewed results of shotgun metagenomic sequencing testing requested on cerebrospinal fluid samples submitted to an outside reference laboratory from December 2017 through December 2019. Of the 53 samples from Mayo Clinic patients, 47 were requested by neurologists, with infectious diseases consultation in 23 cases.
Association Between Behavioral and Learning Outcomes and Single Exposures to Procedures Requiring General Anesthesia Before Age 3: Secondary Analysis of Data From Olmsted County, MN
Hu, Danqing , Zaccariello, Michael J. , Schroeder, Darrell R. , Hanson, Andrew C. , Wilder, Robert T. , Flick, Randall P., Schroeder, Darrell , Warner, David O. , Šprung, Juraj

Mayo Clinic

Anesthesia & Analgesia | September 15, 2020 | Volume: 133 | Issue: 1 | Pages: 160-167

10.1213/ane.0000000000005180 | PMID 32932391 Get It

BACKGROUND: Two prior population-based (children born in Olmsted County, MN), retrospective cohort studies both found that multiple exposures to anesthesia before age 3 were associated with a significant increase in the frequency of attention-deficit hyperactivity disorder (ADHD) and learning disabilities (LD) later in life. The primary purpose of this secondary analysis of these data was to test the hypothesis that a single exposure to anesthesia before age 3 was associated with an increased risk of ADHD. We also examined the association of single exposures with LD and the need for individualized educational plans as secondary outcomes. METHODS: This analysis includes 5339 children who were unexposed to general anesthesia before age 3 (4876 born from 1976 to 1982 and 463 born from 1996 to 2000), and 1054 children who had a single exposure to anesthesia before age 3 (481 born from 1976 to 1982 and 573 born from 1996 to 2000). The primary outcome of interest was ADHD. Secondary outcomes included LD (reading, mathematics, and written language) and the need for individualized educational programs (speech/language and emotion/behavior). To compare the incidence of each outcome between those who were unexposed and singly exposed to anesthesia before the age of 3 years, an inverse probability of treatment weighted proportional hazards model was used. RESULTS: For children not exposed to anesthesia, the estimated cumulative frequency (95% confidence interval [CI]) of ADHD at age 18 was 7.3% (95% CI, 6.5–8.1) and 13.0% (95% CI, 10.1–16.8) for the 1976–1982 and 1996–2000 cohorts, respectively. For children exposed to a single anesthetic before age 3, the cumulative frequency of ADHD was 8.1% (95% CI, 5.3–12.4) and 17.6% (95% CI, 14.0–21.9) for the 1976–1982 and 1996–2000 cohorts, respectively. In weighted analyses, single exposures were not significantly associated with an increased frequency of ADHD (hazard ratio [HR], 1.21; 95% CI, 0.91–1.60; P = .184). Single exposures were also not associated with an increased frequency of any LD (HR, 0.98; 95% CI, 0.78–1.23), or the need for individualized education plans. CONCLUSIONS: This analysis did not find evidence that single exposures to procedures requiring general anesthesia, before age 3, are associated with an increased risk of developing ADHD, LD, or the need for individualized educational plans in later life.
MOG-IgG1 and co-existence of neuronal autoantibodies
Kunchok, Amy , Krecke, Karl N. , Chen, John J. , Caceres, J. , Dominick, Justin, Ferguson, Ian , Kinkel, Revere P., Probasco, John C. , Ruvalcaba, Miguel, Santoro, Jonathan D. , Sieloff, Kurt, Timothy, Jeremy, Weinshenker, Brian G. , Pittock, Sean J, Pittock, Sean J. , Flanagan, E P , Santoro, Jonathan D , Pittock, Sean J , Pittock, S J , Weinshenker, Brian G , Chen, John J , Flanagan, Eoin P. , McKeon, Andrew

Mayo Clinic

Multiple Sclerosis Journal | September 10, 2020 | Volume: 27 | Issue: 8 | Pages: 1175-1186

10.1177/1352458520951046 | PMID 32907470 Get It

Background: The presence of co-existent neuronal antibodies (neuronal-IgG) in patients with myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG1) is not yet well understood. Objectives: The aim of this study was to investigate the co-existence of a broad range of neuronal-IgG in MOG-IgG1+ patients. Methods: MOG-IgG1+ patients were tested for 17 neuronal-IgGs in cerebrospinal fluid (CSF) and serum including NMDA-R-IgG, AMPA-R-IgG, GABAB-R-IgG, LGI1-IgG, CASPR2-IgG, GABAA-R-IgG, GAD65-IgG, mGLUR1-IgG, DPPX-IgG, CRMP5-IgG, amphiphysin-IgG, PCA1,2,Tr, and ANNA1,2,3. Clinical and radiological features of MOG-IgG1+ with NMDA-R-IgG in CSF were compared to a control cohort of MOG-IgG1+ patients without NMDA-R-IgG. Results: A total of 376 MOG-IgG1+ patients underwent testing for neuronal-IgGs. Serum testing for neuronal-IgGs (113 adults, 142 children) identified one child with NMDA-R-IgG (0.7%), one child with CASPR2-IgG (0.7%), one adult with LGI1-IgG (0.9%) and one adult with GABAA-R-IgG (0.9%). CSF testing for neuronal-IgGs (97 adults, 169 children) identified seven children (4%) and seven adults (7%) with NMDA-R-IgG, and one adult with GABAA-R-IgG (1%). The MOG-IgG1+/NMDA-R-IgG+ patients had a median age of 17 (range: 2–39) years. Features associated with MOG-IgG1+/NMDA-R-IgG+ included encephalopathy ( p = 0.001), seizures ( p = 0.045), and leptomeningeal enhancement ( p = 0.045). Conclusion: NMDA-R-IgG was the most frequently detected neuronal-IgG to co-exist with MOG-IgG1. MOG-IgG1+/NMDA-R-IgG+ patients most often presented with encephalopathy and seizures. Testing for MOG-IgG1 and NMDA-R-IgG may be warranted in patients with encephalopathy and inflammatory demyelinating syndromes.
Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia
Di, Li , Chen, Hai , Selcen, Duygu , Engel, Andrew G. , Da, Yuwei , Shen, Xin‐Ming , Shen, Xin-Ming , Di, Li, Lü, Yan

Mayo Clinic

Neurology | September 10, 2020 | Volume: 95 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000010734 | PMID 32907971 Get It